ダウンロード数: 78

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
69_4_107.pdf749.87 kBAdobe PDF見る/開く
タイトル: 膀胱原発印環細胞癌に対してGC療法が有効であった1例
その他のタイトル: A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin
著者: 石井, 信  KAKEN_name
山本, 致之  KAKEN_name
吉村, 明洋  KAKEN_name
林, 拓自  KAKEN_name
川村, 憲彦  KAKEN_name
永原, 啓  KAKEN_name
中井, 康友  KAKEN_name
中山, 雅志  KAKEN_name
西村, 和郎  KAKEN_name
著者名の別形: ISHII, Makoto
YAMAMOTO, Yoshiyuki
YOSHIMURA, Akihiro
HAYASHI, Takuji
KAWAMURA, Norihiko
NAGAHARA, Akira
NAKAI, Yasutomo
NAKAYAMA, Masashi
NISHIMURA, Kazuo
キーワード: Bladder cancer
Signet ring cell carcinoma
Gemcitabine
Cisplatin
発行日: 30-Apr-2023
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 69
号: 4
開始ページ: 107
終了ページ: 112
抄録: A 55-year-old female presented to the hospital with a complaint of gross hematuria. Transurethral resection of bladder tumor was performed. The specimens pathologically showed signet ring cells and no urothelial carcinoma components. Magnetic resonance imaging and computed tomographic (CT) scan revealed bladder tumor, cervical metastasis, bilateral ovarian metastasis, and multiple lymph node metastasis. She was diagnosed with a primary signet ring cell carcinoma of the urinary bladder with cT3bN2M1, and was treated with chemotherapy of gemcitabine and cisplatin combination (GC). After 2 cycles of GC, the value of CEA which was elevated to 106 ng/ml before treatment, became negative. CT scan showed that her disease had successfully responded to the chemotherapy, and remained efficacious till the end of 6 cycles. The patient subsequently received 1 cycle of gemcitabine and nedaplatin and 3 cycles of avelumab due to renal insufficiency. Yet, 14 months after diagnosis, cerebellar metastases appeared and the patient died of meningeal carcinomatosis.
著作権等: 許諾条件により本文は2024-05-01に公開
DOI: 10.14989/ActaUrolJap_69_4_107
URI: http://hdl.handle.net/2433/282079
PubMed ID: 37183041
出現コレクション:Vol.69 No.4

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。